MMP-7 serum levels as predictor or prognostic of cetuximab benefit in the treatment of advanced colorectal cancer: Results from a HCB-05 prospective trial

Authors :: Carles Pericay
Gemma Carrera
Xabier García-Albéniz
M. P. Escudero
Sergi Castellví-Bel
Vicente Alonso
Rosa Gallego
Carlos Fernández-Martos
Virginia Alonso-Espinaco
Juan Maurel
Source :: Journal of Clinical Oncology. 28:10639-10639
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: 10639 Background: To prospectively explore the role of serum MMP-7 as a predictive and prognostic marker of anti-EGFR therapy and irinotecan efficacy in third-line advanced colorectal cancer therap...

Subjects :: Oncology
Advanced colorectal cancer
Irinotecan
Cancer Research
medicine.medical_specialty
Cetuximab
Prospective trial
business.industry
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools